Quentin M Anstee1, Bryan Jaques2, Mark Hudson3, Helen L Reeves4. 1. The Liver Unit, Freeman Hospital, Newcastle-upon-Tyne Hospitals NHS Foundation Trust, UK; Institute of Cellular Medicine, Newcastle University, Newcastle-upon-Tyne, UK. 2. Hepatopancreatobiliary Team, Freeman Hospital, Newcastle-upon-Tyne Hospitals NHS Foundation Trust, UK. 3. The Liver Unit, Freeman Hospital, Newcastle-upon-Tyne Hospitals NHS Foundation Trust, UK. 4. The Liver Unit, Freeman Hospital, Newcastle-upon-Tyne Hospitals NHS Foundation Trust, UK; Hepatopancreatobiliary Team, Freeman Hospital, Newcastle-upon-Tyne Hospitals NHS Foundation Trust, UK; Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, UK. Electronic address: H.L.Reeves@ncl.ac.uk.
Authors: S Pillai; S Duvvuru; P Bhatnagar; W Foster; M Farmen; S Shankar; C Harris; E Bastyr; B Hoogwerf; A Haupt Journal: Pharmacogenomics J Date: 2017-11-21 Impact factor: 3.550